NVDA vs PPCB · P/E 58, rev $96.22B vs P/E 0.0, $3.9M cap
NVIDIA Corporation (NVDA) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
PPCB does not have a complete income-statement cache yet.
NVDA currently screens at market cap $4.40T and trailing P/E 58.2. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the NVDA and PPCB stock pages for the full models.
Not investment advice.